Integra LifeSciences Holdings CorporationIARTNASDAQ
Loading
IART Revenue Growth (YoY Quarterly)•-1.74%
Stock Alarm Pro
Growth Metrics
Latest: Q4 2025vs Q3 2025
Revenue GrowthGross Profit GrowthEBITDA GrowthOperating Income GrowthNet Income GrowthEPS GrowthEPS Diluted GrowthWeighted Average Shares GrowthWeighted Average Shares Diluted GrowthDividends per Share Growth
-1.74%
-7.3pp
-13.53%
-26.5pp
-16.59%
-71.2pp
+1461.17%
+1461.2pp
-108.77%
-108.8pp
-108.88%
-108.9pp
-108.88%
-108.9pp
-0.33%
-0.7pp
-0.33%
-0.7pp
+0.00%
+0.0pp
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +11.49% | +3.74% | -0.61% | +5.57% | -1.74% |
| Gross Profit Growth | +9.97% | -6.00% | -7.34% | +12.92% | -13.53% |
| EBITDA Growth | +7.50% | -33.35% | -1273.42% | +54.59% | -16.59% |
| Operating Income Growth | -1.17% | -490.94% | +0.00% | +0.00% | +1461.17% |
| Net Income Growth | -2.01% | +0.00% | +0.00% | +0.00% | -108.77% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | -108.88% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | -108.88% |
| Weighted Average Shares Growth | -1.68% | -1.64% | -1.22% | +0.40% | -0.33% |
| Weighted Average Shares Diluted Growth | -1.68% | -1.64% | -1.22% | +0.40% | -0.33% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -13.63% | -171.45% | -77.92% | +81.93% | -76.71% |
| Free Cash Flow Growth | -67.30% | -13906.53% | -204.98% | +0.00% | -432.98% |
| Receivables Growth | +5.03% | +4.71% | +2.42% | +5.58% | +2.38% |
| Inventory Growth | +10.13% | +10.41% | +10.28% | +11.94% | +14.83% |
| Asset Growth | +6.75% | -0.62% | -9.98% | -10.31% | -10.78% |
| Book Value per Share Growth | -1.02% | -3.03% | -31.46% | -32.08% | -32.25% |
| Debt Growth | +18.01% | -1.15% | +0.21% | +0.83% | +2.45% |
| R&D Expense Growth | +28.52% | -8.30% | -9.31% | -18.15% | -20.57% |
| SG&A Expenses Growth | +9.44% | +9.47% | -7.97% | -4.60% | -5.18% |
1 / 4